GOLDMAN SACHS GROUP INC - FINCH THERAPEUTICS GROUP INC ownership

FINCH THERAPEUTICS GROUP INC's ticker is FNCH and the CUSIP is 31773D101. A total of 47 filers reported holding FINCH THERAPEUTICS GROUP INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of FINCH THERAPEUTICS GROUP INC
ValueSharesWeighting
Q4 2022$8,225
-80.9%
17,135
-33.4%
0.00%
Q3 2022$43,000
-56.1%
25,716
-25.5%
0.00%
Q2 2022$98,000
-89.7%
34,511
-41.6%
0.00%
Q1 2021$955,00059,1240.00%
Other shareholders
FINCH THERAPEUTICS GROUP INC shareholders Q2 2021
NameSharesValueWeighting ↓
Avenir Management Company, LLC 1,663,366$653,7033.23%
Bleichroeder LP 810,416$318,4930.07%
Ikarian Capital, LLC 237,553$93,3590.02%
LAKE STREET ADVISORS GROUP, LLC 739,136$2910.02%
Baupost Group 2,019,008$7930.01%
Proficio Capital Partners LLC 110,559$43,4500.01%
MSD Partners, L.P. 153,397$60,2850.01%
Ballentine Partners, LLC 143,603$56,4360.00%
SVB WEALTH LLC 253,054$99,4500.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 18,783$7,3820.00%
View complete list of FINCH THERAPEUTICS GROUP INC shareholders